2024 Q2 Form 10-Q Financial Statement

#000190798224000061 Filed on May 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $2.183M $2.465M $1.583M
YoY Change 27.89% 55.72%
Cost Of Revenue $795.0K $806.0K $1.162M
YoY Change -20.66% -30.64% 98.97%
Gross Profit $1.388M $1.659M $421.0K
YoY Change 96.88% 294.06% -62.71%
Gross Profit Margin 63.58% 67.3% 26.6%
Selling, General & Admin $11.87M $10.65M $14.20M
YoY Change -1.59% -24.98% 170.61%
% of Gross Profit 855.33% 641.95% 3371.97%
Research & Development $8.355M $8.525M $10.92M
YoY Change -12.49% -21.9% 67.28%
% of Gross Profit 601.95% 513.86% 2592.64%
Depreciation & Amortization $200.0K $229.0K $339.0K
YoY Change 0.0% -32.45% -17.72%
% of Gross Profit 14.41% 13.8% 80.52%
Operating Expenses $20.23M $19.18M $25.11M
YoY Change -6.41% -23.64% 1048.04%
Operating Profit -$18.84M -$17.52M -$24.69M
YoY Change -9.89% -29.06% 2233.01%
Interest Expense -$1.592M $1.719M $454.0K
YoY Change 40.88% 278.63% 878.87%
% of Operating Profit
Other Income/Expense, Net $1.061M $204.0K $82.00K
YoY Change -121.26% 148.78% -106.4%
Pretax Income -$17.78M -$17.31M -$24.61M
YoY Change -31.36% -29.65% 619.01%
Income Tax
% Of Pretax Income
Net Earnings -$17.80M -$17.30M -$24.60M
YoY Change -31.27% -29.67% 618.77%
Net Earnings / Revenue -815.39% -701.83% -1554.01%
Basic Earnings Per Share -$0.10 -$0.11 -$0.20
Diluted Earnings Per Share -$0.10 -$0.11 -$0.20
COMMON SHARES
Basic Shares Outstanding 126.4M shares 116.8M shares 80.39M shares
Diluted Shares Outstanding 172.1M shares 161.3M shares 123.1M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.06M $27.30M $8.988M
YoY Change 446.75% 203.78% 29129.27%
Cash & Equivalents $40.86M $27.30M $8.988M
Short-Term Investments $200.0K
Other Short-Term Assets $2.349M $2.569M $2.814M
YoY Change 6.77% -8.71% 2181.13%
Inventory $2.126M $2.079M $2.240M
Prepaid Expenses
Receivables $1.570M $1.735M $542.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $46.91M $33.69M $14.91M
YoY Change 265.25% 125.91% 9576.21%
LONG-TERM ASSETS
Property, Plant & Equipment $3.212M $2.909M $2.041M
YoY Change 79.24% 42.53% -82.0%
Goodwill
YoY Change
Intangibles $408.0K $302.0K $228.0K
YoY Change 99.02% 32.46%
Long-Term Investments $2.396M $2.574M
YoY Change
Other Assets $3.705M $3.828M $1.351M
YoY Change 173.63% 183.35% -0.22%
Total Long-Term Assets $14.91M $14.92M $12.55M
YoY Change 23.52% 18.9% -95.82%
TOTAL ASSETS
Total Short-Term Assets $46.91M $33.69M $14.91M
Total Long-Term Assets $14.91M $14.92M $12.55M
Total Assets $61.81M $48.61M $27.46M
YoY Change 148.15% 77.01% -90.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.168M $1.037M $8.067M
YoY Change -71.58% -87.15% 164.32%
Accrued Expenses $5.038M $6.007M $9.859M
YoY Change -53.35% -39.07% 26.19%
Deferred Revenue $2.590M $1.999M $1.827M
YoY Change -8.38% 9.41%
Short-Term Debt $0.00 $0.00 $420.0K
YoY Change -100.0% -100.0% 110.0%
Long-Term Debt Due $32.67M $369.0K $790.0K
YoY Change 105.32% -53.29% -94.83%
Total Short-Term Liabilities $42.94M $10.86M $18.08M
YoY Change 27.64% -39.95% 266.85%
LONG-TERM LIABILITIES
Long-Term Debt $31.45M $63.04M $8.260M
YoY Change 271.19% 663.23%
Other Long-Term Liabilities $8.933M $11.66M $8.428M
YoY Change -16.44% 38.34% -62.66%
Total Long-Term Liabilities $31.45M $63.04M $8.260M
YoY Change 271.19% 663.23% -63.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.94M $10.86M $18.08M
Total Long-Term Liabilities $31.45M $63.04M $8.260M
Total Liabilities $83.33M $85.56M $34.77M
YoY Change 57.81% 146.07% 26.45%
SHAREHOLDERS EQUITY
Retained Earnings -$518.2M -$500.4M -$401.4M
YoY Change 21.27% 24.66%
Common Stock $18.00K $16.00K $12.00K
YoY Change 50.0% 33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$21.51M -$36.96M -$7.313M
YoY Change
Total Liabilities & Shareholders Equity $61.81M $48.61M $27.46M
YoY Change 148.15% 77.01% -90.86%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$17.80M -$17.30M -$24.60M
YoY Change -31.27% -29.67% 618.77%
Depreciation, Depletion And Amortization $200.0K $229.0K $339.0K
YoY Change 0.0% -32.45% -17.72%
Cash From Operating Activities -$14.47M -$12.10M -$13.60M
YoY Change -6.48% -11.03% 4526.32%
INVESTING ACTIVITIES
Capital Expenditures $458.0K $305.0K $64.00K
YoY Change 376.56% -144.44%
Acquisitions
YoY Change
Other Investing Activities -$146.0K -$813.0K
YoY Change
Cash From Investing Activities -$604.0K -$1.205M -$76.00K
YoY Change 1485.53% -47.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $881.0K
YoY Change -100.0% 6676.92%
Cash From Financing Activities 28.61M -$726.0K $15.59M
YoY Change 103.32% -104.66% 7696.0%
NET CHANGE
Cash From Operating Activities -14.47M -$12.10M -$13.60M
Cash From Investing Activities -604.0K -$1.205M -$76.00K
Cash From Financing Activities 28.61M -$726.0K $15.59M
Net Change In Cash 13.54M -$14.00M $1.923M
YoY Change -1066.79% -828.19% -2146.4%
FREE CASH FLOW
Cash From Operating Activities -$14.47M -$12.10M -$13.60M
Capital Expenditures $458.0K $305.0K $64.00K
Free Cash Flow -$14.93M -$12.41M -$13.66M
YoY Change -3.52% -9.21% 9011.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1652000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2078000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2009000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
47046000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2551000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8223000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
179000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1357000 usd
CY2023Q4 us-gaap Assets
Assets
59356000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1465000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5343000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1999000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10860000 usd
CY2024Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4282000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6978000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2465000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1735000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
2079000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2569000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
33687000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2909000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7879000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
302000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3828000 usd
CY2024Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1037000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6007000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1162000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
1659000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
421000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17312000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-19000 usd
CY2024Q1 us-gaap Assets
Assets
48605000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1448000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1374000 usd
CY2024Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
369000 usd
CY2023Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
399000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2669000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11250000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1630000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7028000 usd
CY2024Q1 qbts Long Term Debt Noncurrent Fair Value
LongTermDebtNoncurrentFairValue
31100000 usd
CY2023Q4 qbts Long Term Debt Noncurrent Fair Value
LongTermDebtNoncurrentFairValue
31400000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63043000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63850000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
399000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
79000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
85562000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
83837000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161675010 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161675010 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161113744 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161113744 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
16000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
16000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
473870000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
469081000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-500373000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-483061000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10470000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10517000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-36957000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-24481000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48605000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59356000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1583000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
806000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8525000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10915000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7566000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11296000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3084000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2900000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
19175000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
25111000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-17516000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-24690000 usd
CY2024Q1 us-gaap Interest Expense Other
InterestExpenseOther
1140000 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
212000 usd
CY2024Q1 qbts Fair Value Adjustment Of Debt Instrument
FairValueAdjustmentOfDebtInstrument
-1199000 usd
CY2023Q1 qbts Fair Value Adjustment Of Debt Instrument
FairValueAdjustmentOfDebtInstrument
0 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
1660000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2652000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-638000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1137000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-142000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
204000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
284000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17312000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24406000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161308490 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161308490 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123144097 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
123144097 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17312000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24406000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
47000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-19000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17265000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24425000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-24481000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5515000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
734000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
47000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-36957000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-29463000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15683000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
546000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6755000 usd
CY2023Q1 qbts Adjustments To Additional Paid In Capital Short Swing Profit Settlement
AdjustmentsToAdditionalPaidInCapitalShortSwingProfitSettlement
244000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24406000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-30660000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17312000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24406000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
229000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
339000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3509000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6755000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
199000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
206000 usd
CY2024Q1 qbts Noncash Interest Expense Income
NoncashInterestExpenseIncome
1093000 usd
CY2023Q1 qbts Noncash Interest Expense Income
NoncashInterestExpenseIncome
195000 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2652000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-638000 usd
CY2024Q1 qbts Fair Value Adjustment Of Debt Instrument
FairValueAdjustmentOfDebtInstrument
-1199000 usd
CY2023Q1 qbts Fair Value Adjustment Of Debt Instrument
FairValueAdjustmentOfDebtInstrument
0 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
1660000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
994000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-84000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-215000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
59000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
559000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-767000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-538000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1858000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2597000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1214000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-350000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
46000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
343000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-150000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
68000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12119000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13574000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
305000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
64000 usd
CY2024Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
1000000 usd
CY2023Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
254000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
CY2024Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
67000 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0 usd
CY2024Q1 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
87000 usd
CY2023Q1 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
12000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1205000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15683000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
546000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
734000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2024Q1 qbts Proceeds From Short Swing Profit Settlement
ProceedsFromShortSwingProfitSettlement
0 usd
CY2023Q1 qbts Proceeds From Short Swing Profit Settlement
ProceedsFromShortSwingProfitSettlement
244000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
881000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-726000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15592000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-19000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14003000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1923000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41307000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7065000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27304000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8988000 usd
CY2024Q1 qbts Transfer From Inventory To Property Plant And Equipment
TransferFromInventoryToPropertyPlantAndEquipment
18000 usd
CY2023Q1 qbts Transfer From Inventory To Property Plant And Equipment
TransferFromInventoryToPropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
365000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 qbts Purchase Sale Of Property Plant And Equipment Included In Accounts Payable Accounts Receivable
PurchaseSaleOfPropertyPlantAndEquipmentIncludedInAccountsPayableAccountsReceivable
234000 usd
CY2023Q1 qbts Purchase Sale Of Property Plant And Equipment Included In Accounts Payable Accounts Receivable
PurchaseSaleOfPropertyPlantAndEquipmentIncludedInAccountsPayableAccountsReceivable
0 usd
CY2024Q1 qbts Stock Based Compensation Issued
StockBasedCompensationIssued
2006000 usd
CY2023Q1 qbts Stock Based Compensation Issued
StockBasedCompensationIssued
0 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. DESCRIPTION OF BUSINESS</span></div><div style="margin-bottom:0.11pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave Quantum Inc. ("D-Wave" or the “Company”) was incorporated under the General Corporation Law of the State of Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Merger”) pursuant to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Merger, DPCM and D-Wave Systems became wholly-owned subsidiaries of, and are operated by, the Company. Upon the completion of the Merger, the Company succeeded to all of the operations of its predecessor, D-Wave Systems. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave is a commercial quantum computing company that provides customers with a full suite of professional services and web-based access to its superconducting quantum computer systems and integrated software environment through its cloud service, Leap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Historically, the Company has developed its own annealing superconducting quantum computer and associated software, and its current generation quantum system is the Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> system.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave has three operating facilities, which it leases, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, and Palo Alto, California.</span></div>
CY2024Q1 qbts Number Of Operating Facilities
NumberOfOperatingFacilities
3 facility
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-500400000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17300000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-24400000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12100000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13600000 usd
CY2024Q1 us-gaap Cash
Cash
27300000 usd
CY2024Q1 qbts Working Capital Deficit
WorkingCapitalDeficit
-22800000 usd
CY2024Q1 us-gaap Assets Net
AssetsNet
-37000000 usd
CY2022Q2 qbts Equity Line Of Credit Right To Sell Common Stock
EquityLineOfCreditRightToSellCommonStock
150000000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 qbts Equity Line Of Credit Ownership Restriction Percentage
EquityLineOfCreditOwnershipRestrictionPercentage
0.099
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 qbts Equity Line Of Credit Floor Stock Price
EquityLineOfCreditFloorStockPrice
1.00
CY2022Q2 qbts Equity Line Of Credit Floor Stock Price
EquityLineOfCreditFloorStockPrice
1.00
CY2022Q2 qbts Equity Line Of Credit Floor Stock Price
EquityLineOfCreditFloorStockPrice
1.00
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. The most significant estimates and assumptions are used in determining: (i) inputs used to recognize revenue over time relating to hours estimated to complete the remaining performance obligations, (ii) fair value of financial instruments, and (iii) long term revenue forecasts used in the accounting for the SIF Loan (see below and Note 6 for further information). These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.</span></div>The Company’s accounting estimates and assumptions may change over time in response to risks and uncertainties, including uncertainty in the current economic environment due to inflation, increased interest rates, Ukraine/Russia conflict, the Israel-Hamas War, and any evolutions thereof. The change could be material in future periods. As of the date of issuance of these condensed consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.
CY2024Q1 qbts Contract With Customer Deposit Liability
ContractWithCustomerDepositLiability
45000 usd
CY2023Q4 qbts Contract With Customer Deposit Liability
ContractWithCustomerDepositLiability
45000 usd
CY2024Q1 qbts Contract With Customer Liability And Deposit
ContractWithCustomerLiabilityAndDeposit
2443000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2465000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1583000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2465000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1583000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2465000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1583000 usd
CY2024Q1 qbts Accounts Receivable After Allowance For Credit Loss Excluding Unbilled Receivables Current
AccountsReceivableAfterAllowanceForCreditLossExcludingUnbilledReceivablesCurrent
1098000 usd
CY2023Q4 qbts Accounts Receivable After Allowance For Credit Loss Excluding Unbilled Receivables Current
AccountsReceivableAfterAllowanceForCreditLossExcludingUnbilledReceivablesCurrent
644000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
637000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1008000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1999000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2669000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
399000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
79000 usd
CY2023Q4 qbts Contract With Customer Liability And Deposit
ContractWithCustomerLiabilityAndDeposit
2793000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1400000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1200000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2748000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1790000 usd
CY2024Q1 qbts Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
2113000 usd
CY2023Q1 qbts Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1166000 usd
CY2024Q1 qbts Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
2463000 usd
CY2023Q1 qbts Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
1120000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2398000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1836000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7400000 usd
CY2024Q1 qbts Revenue Remaining Performance Obligation Percentage To Be Recognized In Year One
RevenueRemainingPerformanceObligationPercentageToBeRecognizedInYearOne
0.57
CY2024Q1 qbts Revenue Remaining Performance Obligation Percentage To Be Recognized In Years One And Two
RevenueRemainingPerformanceObligationPercentageToBeRecognizedInYearsOneAndTwo
0.91
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2054000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2052000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
25000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
26000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
2079000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2078000 usd
CY2024Q1 qbts Prepaid Services Current
PrepaidServicesCurrent
736000 usd
CY2023Q4 qbts Prepaid Services Current
PrepaidServicesCurrent
386000 usd
CY2024Q1 qbts Prepaid Software Current
PrepaidSoftwareCurrent
588000 usd
CY2023Q4 qbts Prepaid Software Current
PrepaidSoftwareCurrent
543000 usd
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
537000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
490000 usd
CY2024Q1 us-gaap Prepaid Rent
PrepaidRent
148000 usd
CY2023Q4 us-gaap Prepaid Rent
PrepaidRent
150000 usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
560000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
440000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2569000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2009000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
1168000 usd
CY2024Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1021000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
0 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
189000 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
189000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
2574000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
44000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
0 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3828000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1357000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
1700000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2080000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3245000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1420000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1092000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2507000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1006000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6007000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5343000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27139000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26604000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24230000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24053000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2909000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2551000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
200000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
300000 usd
CY2024Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
369000 usd
CY2023Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
399000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63043000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63850000 usd
CY2024Q1 qbts Long Term Debt Noncurrent Amortized Cost
LongTermDebtNoncurrentAmortizedCost
31943000 usd
CY2023Q4 qbts Long Term Debt Noncurrent Amortized Cost
LongTermDebtNoncurrentAmortizedCost
32450000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63043000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63850000 usd
CY2024Q1 qbts Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
17916609 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2024Q1 qbts Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Prior To Exchange Ratio
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPriorToExchangeRatio
11.50
CY2022Q3 qbts Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
1.4541326
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.91
CY2024Q1 qbts Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.10
CY2024Q1 qbts Class Of Warrant Or Right Redemption Notice Period
ClassOfWarrantOrRightRedemptionNoticePeriod
P30D
CY2024Q1 qbts Class Of Warrant Or Right Redemption Share Price Threshold Trading Days
ClassOfWarrantOrRightRedemptionSharePriceThresholdTradingDays
20 day
CY2024Q1 qbts Class Of Warrant Or Right Redemption Share Price Threshold Consecutive Trading Days
ClassOfWarrantOrRightRedemptionSharePriceThresholdConsecutiveTradingDays
P30D
CY2022Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2024Q1 qbts Class Of Warrant Or Right Reference Value
ClassOfWarrantOrRightReferenceValue
18.00
CY2024Q1 qbts Class Of Warrant Or Right Redemption Notice Period
ClassOfWarrantOrRightRedemptionNoticePeriod
P30D
CY2022Q3 qbts Class Of Warrant Or Right Conversion Ratio
ClassOfWarrantOrRightConversionRatio
0.889657
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1155713 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1155713 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11464447 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.64
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2921082 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.30
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10443 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.91
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
122179 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.35
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14252907 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.56
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M23D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12718000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11573180 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.29
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M29D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11406000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2679727 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.74
CY2024Q1 qbts Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm
P8Y11M4D
CY2024Q1 qbts Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14252907 shares
CY2024Q1 qbts Share Based Compensation Arrangement By Share Based Payment Award Options To Be Issued Upon Exercise
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeIssuedUponExercise
9294878 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P9Y29D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P12Y6M18D
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3509000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6755000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
30200000 usd
CY2024Q1 qbts Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.027
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M1D
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
500000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
400000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17312000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17312000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-24406000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24406000 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161308490 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161308490 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
123144097 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123144097 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
50769158 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41969131 shares
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001907982-24-000061-index-headers.html Edgar Link pending
0001907982-24-000061-index.html Edgar Link pending
0001907982-24-000061.txt Edgar Link pending
0001907982-24-000061-xbrl.zip Edgar Link pending
exhibit311-q12024.htm Edgar Link pending
exhibit312-q12024.htm Edgar Link pending
exhibit321-q12024.htm Edgar Link pending
exhibit322-q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qbts-20240331.htm Edgar Link pending
qbts-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
qbts-20240331_cal.xml Edgar Link unprocessable
qbts-20240331_def.xml Edgar Link unprocessable
qbts-20240331_pre.xml Edgar Link unprocessable
qbts-20240331_lab.xml Edgar Link unprocessable
qbts-20240331_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable